GenScript Strengthens Asia-Pacific Presence with New Sydney Operations Center

GenScript Biotech Corporation has officially expanded its footprint in Sydney, Australia, with the opening of a new logistics and operations center. This facility marks a significant step in strengthening the company's presence in the Asia-Pacific region while supporting Australia’s rapidly growing biotechnology sector. By localizing operations, GenScript aims to streamline the delivery of essential research reagents and products to researchers and biotech companies in the region.

The Sydney center promises a range of operational benefits, including next-day shipping for key high-demand products such as mRNA, growth factors, and Cas proteins. This will greatly reduce logistical complexities such as customs clearance and tax payments, allowing researchers to focus on their scientific advancements. The next-day shipping service is expected to be a game-changer for biotech companies, enabling faster access to critical materials for ongoing research projects.

GenScript’s rotating CEO, Sherry Shao, emphasized that this expansion is not just about operational efficiency but also about building long-term relationships within the local biotech ecosystem. Dr. Janice Jin, President of GenScript Asia Pacific, echoed these sentiments, highlighting Australia's pivotal role in the biotech landscape. This new facility is poised to foster innovation by ensuring faster, more efficient access to GenScript's high-quality products and services, thus empowering the region’s research and development efforts.